The 50 references in paper E. Lysova V., N. Savenkova D., Е. Лысова В., Н. Савенкова Д. (2014) “Особенности синдрома анемии при хронической болезни почек у детей (обзор литературы) // Features of syndrome anemia in children with chronic kidney disease” / spz:neicon:nefr:y:2014:i:3:p:34-44

1
Koshy SM, Geary DF. Anemia in children with chronic kidney disease. Pediatr Nephrol 2008; 23: 209–219
(check this in PDF content)
2
The National Institute for Health and Clinical Excellence (NICE). National costing report: anaemia management in people with CKD. Implementing NICE guidance in England. Issued: February 2011. This updates and replaces NICE clinical guideline 39
(check this in PDF content)
3
Папаян АВ, Жукова ЛЮ. Анемии у детей: руководство для врачей. Питер, СПб., 2001:351-358
(check this in PDF content)
4
KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney International Supplements (2012);2:331–335
(check this in PDF content)
5
Наумова В.И., Папаян А.В. Почечная недостаточность у детей. Медицина, Л., 1991;177 -189
(check this in PDF content)
6
Atkinson MA, Pierce CB, Zack RM et al. Hemoglobin differences by race in children with CKD. Am J Kidney Dis 2010;55(6):1009–1017
(check this in PDF content)
7
VanDeVoorde R, Warady BA. Management of Chronic Kidney Disease. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N, eds. Pediatric Nephrology , 6th. Heidelberg: Springer, Berlin, 2009;(2):1660-1692
(check this in PDF content)
8
Atkinson MA, Furth SL. Anemia in children with chronic kidney disease. Nat Rev Nephrol 2011; 7:635–641
(check this in PDF content)
9
Jelkmann W. Physiology and pharmacology of erythropoietin. Transfus Med Hemother 2013;40(5):302–309
(check this in PDF content)
10
Nangaku M, Eckardt KU. Hypoxia and the HIF system in kidney disease. J Mol Med 2007; 85(12):1325–1330
(check this in PDF content)
11
Hamed EA, El-Abaseri TB, Mohamed AO et al. Hypoxia and oxidative stress markers in pediatric patients undergoing hemodialysis: cross section study. BMC Nephrol 2012(13); 13:136
(check this in PDF content)
12
Левина АА, Макешова АБ, Мамукова ЮИ, и соавт. Регуляция гомеостаза кислорода. Фактор, индуцированный гипоксией (HIF) и его значение в гомеостазе кислорода. Педиатрия. Журнал им. Г.Н. Сперанского 2009;88(4): 92-97
(check this in PDF content)
13
Haase VH. Hypoxia-inducible factors in the kidney. Am J Physiol Renal Physiol 2006; 291: 271–281
(check this in PDF content)
14
Gunaratnam L, Bonventre JV. HIF in kidney disease and development. J Am Soc Nephrol 2009;20(9): 1877–1887
(check this in PDF content)
15
Hung TW, Liou JH, Yeh KT et al. Renal expression of hypoxia inducible factor-1α in patients with chronic kidney disease: a clinicopathologic study from nephrectomized kidneys. Indian J Med Res 2013; 137(1): 102-110
(check this in PDF content)
16
Kimura K, Iwano M, Higgins DF et al. Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol 2008; 295(4):1023-1029
(check this in PDF content)
17
Haase VH Hypoxia-inducible factor signaling in the development of kidney fibrosis. Fibrogenesis Tissue Repair 2012;5[Supp l]:16
(check this in PDF content)
18
Bolati D, Shimizu H, Yisireyili M et al. Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-кB. BMC Nephrology 2013, 14:56
(check this in PDF content)
19
Goodnough LT, Nemeth E, Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood
(check this in PDF content)
20
0;116(23): 4754-4761 20. Baracco R, Saadeh S, Valentini R. Iron deficiency in children with early chronic kidney disease. Pediatric Nephrol 2011; 26(11):2077-2080
(check this in PDF content)
21
Atkinson MA, Pierce CB, Fadrowski JJ. Association between common iron store markers and hemoglobin in children with chronic kidney disease. Pediatr Nephrol 2012; 27(12):2275-2283
(check this in PDF content)
22
Левина АА, Казюкова ТВ, Цветаева НВ. Гепсидин как регулятор гомеостаза железа. Педиатрия. Журнал им. Г.Н. Сперанского 2008; 87(1):67-74
(check this in PDF content)
23
Park CH, Valore EV, Waring A.J. et al. Hepcidin: a urinary antibacterial peptide synthesized in the liver. J Biol Chem 2001; 276(11): 7806–7810
(check this in PDF content)
24
Hunter HN, Fulton DB, Ganz T, Vogel HJ. The solution structure of human hepcidin, a antibicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 2002; 277(40): 37597–37603
(check this in PDF content)
25
Coyne DW. Hepcidin: utility as a diagnostic tool and therapeutic target. Kidney Int 2011;80(3):240-244
(check this in PDF content)
26
Kemma E, Pickkers P, Nemeth E et al. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 2005;106(5):1864-1866
(check this in PDF content)
27
Goldstein, S L, Leung, JC, Silverstein DM. Pro- and antiinflammatory cytokines in chronic pediatric dialysis patients: effect of aspirin. Clin J Am Soc Nephrol 2006; 1(5):979–986
(check this in PDF content)
28
Zaritsky J, Young B, Wang HJ et al. Hepcidin—a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol 2009; 4(6): 1051–1056
(check this in PDF content)
29
Malyszko J, Mysliwiec M. Hepcidin in anemia and inflammation in chronic kidney disease. Kidney Blood Press Res 2007;
(check this in PDF content)
30
1): 15–30 30. Reuter S. E., Faull R. J., Ranieri E., Evans A. M. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients. Nephrol Dial Transplant 2009; 24(3): 990–996
(check this in PDF content)
31
Costa E., Pereira B. J., Rocha-Pereira P. et al. Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients. Am J Nephrol 2008; 28(4): 677–683
(check this in PDF content)
32
Costa E, Lima M, Alves JM et al. Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. J Clin Immunol 2008; 28(3): 268–275
(check this in PDF content)
33
Al-Hilali N, Al-Humoud H, Ninan VT et al. Does parathyroid hormone affect erythropoietin therapy in dialysis patients? Med Princ Pract 2007; 16(1): 63–67
(check this in PDF content)
34
Pronai W, Riegler-Keil M, Silberbauer K, Stockenhuber F. Folic acid supplementation improves erythropoietin response. Nephron1995;71(4): 395-400
(check this in PDF content)
35
Atkinson MA, Martz K, Warady BA, Neu AM. Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS. Pediatr. Nephrol 2010; 25(9): 1699–1706
(check this in PDF content)
36
Добронравов ВА, Смирнов AB, Безруких АМ и соавт. Анемия и преддиализные стадии хронической болезни почек: клиническое значение, распространенность и факторы. Нефрология 2006;10(3): 7-13
(check this in PDF content)
37
Fadrowski JJ, Pierce CB, Cole SR et al. Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. Clin J Am Soc Nephrol 2008;3(2): 457–462
(check this in PDF content)
38
Hollowell JG, Van Assendelft OW, Gunter EW et al. Hematological and iron-related analytes – reference data for persons aged 1 year and over: United States, 1988–1994. Vital Health Stat 11, 2005;(247):1–156
(check this in PDF content)
39
Staples AO, Wong CS, Smith JM et al. Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin J Am Soc Nephrol 2009; 4(1): 48–56
(check this in PDF content)
40
Mc Clellan W, Aronoff SL, Bolton WK at al. The prevalence of anemia in patients with chronic kidney disease. Curr Med Ress Opion 2004; 20(9): 1501–1510
(check this in PDF content)
41
Жетишев PA, Мамбетова АМ. Анемический синдром у детей и подростков с хронической почечной недостаточностью. Педиатрия. Журнал им. Г.Н. Сперанского 2005;4:39-41
(check this in PDF content)
42
Artunc F, Risler Т. Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease. Nephrology Dialysis Transplantation 2007; 22(10):29002908
(check this in PDF content)
43
Маковецкая ГА, Мазур ЛИ, Балашова ЕА. Особенности формирования анемии при хронической болезни почек у детей. Педиатрия. Журнал имени Г.Н. Сперанского 2009;88(3):6-12
(check this in PDF content)
44
Khosroshahia HTB, Shojac MMB, Tubbsd RSB et al. Serum Erythropoietin Levels and Their Correlation With the Erythropoietic System in Hemodialysis Patients and Renal Allograft Recipients. Transplant Proc 2007; 39(4):1051-1053
(check this in PDF content)
45
Amaral S, Hwang W, Fivush B et al. Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis. Clin J Am Soc Nephrol 2008; 3(3):759–767
(check this in PDF content)
46
Greenbaum LA. Anemia in Chronic Renal Disease. In: Geary DF, Schaefer F. Comprehensive Pediatric Nephrology (First Edition), Mosby Elsevier Philadelphia, 2008:761-772
(check this in PDF content)
47
Mitsnefes, MM. et al. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J Pediatr 2006; 149(5):671–675
(check this in PDF content)
48
Gouva C, Nikolopoulos P, Ioannidis JP, Siamopoulos KC. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 2004; 66(2):753–760
(check this in PDF content)
49
Furth SL, Cole SR, Fadrowski JJ et al. The association of anemia and hypoalbuminemia with accelerated decline in GFR among adolescents with chronic kidney disease. Pediatr Nephrol 2007; 22(2): 265–271
(check this in PDF content)
50
Borzych-Duzalka D, Bilginer Y, Ha IS et all. Management of anemia in children receiving chronic peritoneal dialysis. J Am Soc Nephrol 2013;24(4):665-676 Авторы заявляют об отсутствии конфликта интересов.
(check this in PDF content)